High mobility group protein A2 overexpression indicates poor prognosis for cancer patients: a meta-analysis

Overexpression of the high mobility group protein A2 (HMGA2), an architectural transcription factor, has been linked to poor prognosis in many malignancies, although this remains controversial. Herein, we conducted a meta-analysis to investigate whether HMGA2 has prognostic value, and evaluated the...

Descripción completa

Detalles Bibliográficos
Autores principales: Nie, Dan, Zhang, Lingping, Guo, Qian, Mao, Xiguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787434/
https://www.ncbi.nlm.nih.gov/pubmed/29416690
http://dx.doi.org/10.18632/oncotarget.23085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787434/
https://www.ncbi.nlm.nih.gov/pubmed/29416690
http://dx.doi.org/10.18632/oncotarget.23085

Ejemplares similares